Apolipoprotein C Subtype Distribution in Type 2 Diabetes Mellitus

Plasma lipid levels and apolipoprotein C (apo C) composition of VLDL were investigated in a group of Type 2 diabetic patients at first attendance at the outpatient clinic and before any therapeutic intervention. Patients were distributed into two groups of 26 individuals, normo‐and hyperlipidaemic, respectively, and compared with two matched control groups. Normolipidaemic diabetic patients had higher serum triglycerides, VLDL cholesterol, and lower HDL cholesterol than matched normolipidaemic control subjects. While hyperlipidaemic non‐diabetic individuals showed increased apo C II and decreased apo C III‐1 percentages when compared with normolipidaemic non‐diabetic individuals (12.1 ± 4.9 vs 8.5 ± 3.2% and 44.0 ± 6.7 vs 48.1 ± 7.0%, respectively, mean ± SD, both with p < 0.05), the relative distribution of apo C III isoforms and apo CII was similar in both normo‐ and hyperlipidaemic diabetic patients.

[1]  B. Howard,et al.  Lipoprotein metabolism in diabetes mellitus. , 1987, Journal of lipid research.

[2]  G. Reaven.  Non-insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism, and atherosclerosis. , 1987, Metabolism: clinical and experimental.

[3]  S. Grundy,et al.  Effects of NIDDM on Very-Low-Density Lipoprotein Triglyceride and Apolipoprotein B Metabolism: Studies Before and After Sulfonylurea Therapy , 1986, Diabetes.

[4]  G. Reaven,et al.  Effects of noninsulin-dependent diabetes mellitus on the uptake of very low density lipoproteins by thioglycolate-elicited mouse peritoneal macrophages. , 1985, The Journal of clinical endocrinology and metabolism.

[5]  C. S. Wang,et al.  Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III. , 1985, The Journal of clinical investigation.

[6]  P. Halushka,et al.  New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. , 1983, The American journal of medicine.

[7]  U. Garbin,et al.  Ultrathin-layer isoelectric focusing separation of apoprotein C of human very low density lipoproteins. , 1983, Clinica chimica acta; international journal of clinical chemistry.

[8]  P. Bachorik.  Collection of blood samples for lipoprotein analysis. , 1982, Clinical chemistry.

[9]  D. Galton,et al.  An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. , 1982, The Journal of clinical investigation.

[10]  A. Kissebah,et al.  Integrated Regulation of Very Low Density Lipoprotein Triglyceride and Apolipoprotein-B Kinetics in Non-insulin-dependent Diabetes Mellitus , 1982, Diabetes.

[11]  R. Goldberg.  Lipid Disorders in Diabetes , 1981, Diabetes Care.

[12]  O. Ganda.  Pathogenesis of Macrovascular Disease in the Human Diabetic , 1980, Diabetes.

[13]  N. Kalant,et al.  Composition of serum very-low-density and high-density lipoproteins in diabetes. , 1980, Clinical chemistry.

[14]  W. Hazzard,et al.  Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. , 1979, Clinical chemistry.

[15]  L. Simons,et al.  Coronary Risk Factor Screening and Long‐Term Follow Up: year 1 of the sydney coronary heart disease prevention programme , 1978, The Medical journal of Australia.

[16]  G. Schonfeld,et al.  Apolipoprotein B Levels and Altered Lipoprotein Composition in Diabetes , 1974, Diabetes.

[17]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.

[18]  J. Larosa,et al.  A specific apoprotein activator for lipoprotein lipase. , 1970, Biochemical and biophysical research communications.

[19]  Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society. , 1987, European heart journal.

[20]  A. Wahlefeld.  Triglycerides Determination after Enzymatic Hydrolysis , 1974 .

[21]  G R Cooper,et al.  Classification of hyperlipidaemias and hyperlipoproteinaemias. , 1970, Bulletin of the World Health Organization.